CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Yiyi Yan(WinnMed), Haidong Dong(Mayo Clinic in Arizona)
JCI Insight
April 18, 2018
Cited by 182


Related Papers